echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Antitumor Therapy > Good news for breast cancer patients!

    Good news for breast cancer patients!

    • Last Update: 2022-04-23
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Trastuzumab, Emmett, constantly explores the cure and survival of breast cancer patients.


    Using medical evidence to provide a strong backing for clinical diagnosis and treatment of early breast cancer and advanced breast cancer ADC drugs, a "biological magic missile" for anti-tumorEqual emphasis on cost and benefit: direct price reduction of 52% of trastuzumab, improving drug accessibility and meeting patient needsLooking forward to entering medical insurance to benefit more breast cancer patientsleave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.